loading

Revelation Biosciences Inc Borsa (REVB) Ultime notizie

pulisher
10:02 AM

Revelation Biosciences Gains Momentum as FDA Agreement Sparks Hope - StocksToTrade

10:02 AM
pulisher
08:38 AM

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Decline After 2 Consecutive Days Of Gains—Intel, CSX In Focus (UPDATED) - Benzinga

08:38 AM
pulisher
07:13 AM

Revelation Biosciences (REVB) Secures FDA Agreement for Gemini Drug's Clinical Trial Pathway - Intellectia AI

07:13 AM
pulisher
02:02 AM

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours? - Benzinga

02:02 AM
pulisher
01:18 AM

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - citizen-times.com

01:18 AM
pulisher
Jan 22, 2026

Revelation Biosciences reaches FDA agreement on AKI treatment pathway By Investing.com - Investing.com Nigeria

Jan 22, 2026
pulisher
Jan 22, 2026

Revelation Biosciences Reaches FDA Agreement on Gemini for AKI - TradingView — Track All Markets

Jan 22, 2026
pulisher
Jan 21, 2026

Targets Report: What is Revelation Biosciences Inc. Equity Warrant’s valuation compared to sectorWeekly Trade Report & Long Hold Capital Preservation Tips - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 21, 2026

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - USA Today

Jan 21, 2026
pulisher
Jan 21, 2026

Revelation Biosciences reaches FDA agreement on AKI treatment pathway - Investing.com

Jan 21, 2026
pulisher
Jan 21, 2026

Upcoming EventsRevelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - FinancialContent

Jan 21, 2026
pulisher
Jan 21, 2026

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - delawareonline.com

Jan 21, 2026
pulisher
Jan 20, 2026

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - newportri.com

Jan 20, 2026
pulisher
Jan 20, 2026

Will Revelation Biosciences Inc. Equity Warrant benefit from green energy policiesDay Trading Setups & Free Unlock Rapid Growth Potential - bollywoodhelpline.com

Jan 20, 2026
pulisher
Jan 19, 2026

Will Revelation Biosciences Inc. Equity Warrant be affected by tariffsDollar Strength & Low Drawdown Investment Ideas - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 18, 2026

How Revelation Biosciences Inc. stock trades before earningsMarket Trend Report & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 18, 2026

Treasury Yields: Is PLYA likely to announce a buybackJuly 2025 Spike Watch & AI Driven Price Forecasts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 15, 2026

Revelation Biosciences (REVB) to Present Kidney Disease Treatment Data at Conference - Intellectia AI

Jan 15, 2026
pulisher
Jan 15, 2026

Revelation Bio To Share New Data From PRIME Study Of Gemini In March - Nasdaq

Jan 15, 2026
pulisher
Jan 15, 2026

EPS Watch: Will ZBAI stock recover after earningsGlobal Markets & Weekly High Return Opportunities - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

Breakout Zone: Can Revelation Biosciences Inc lead its sector in growth2025 Market Trends & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Whittier Daily News - FinancialContent

Jan 14, 2026
pulisher
Jan 14, 2026

New kidney study to show how Gemini may help acute injury patients - Stock Titan

Jan 14, 2026
pulisher
Jan 13, 2026

Aug Opening: What risks investors should watch in Revelation Biosciences Inc Equity Warrant stock - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

Wall Street Recap: Can Revelation Biosciences Inc beat the S P 500Weekly Trade Review & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 12, 2026

Earnings Recap: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policiesEarnings Summary Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 12, 2026

Biotech recruits new employee with 90,000 stock units over 2 years - Stock Titan

Jan 12, 2026
$101.02
price down icon 3.79%
$33.69
price up icon 1.75%
$118.65
price down icon 0.21%
$116.59
price down icon 1.67%
$155.16
price down icon 3.41%
biotechnology ONC
$338.86
price up icon 0.13%
Capitalizzazione:     |  Volume (24 ore):